Lightlake Therapeutics, which is developing intranasal naloxone to treat eating disorders, has announced the appointment of board member Kevin Pollack as Chief Financial Officer. Pollack joined the board of directors in April 2012. Lightlake Chief Executive Roger Crystal said, "It has been a privilege to work with Kevin since he joined our Board and when we look to … [Read more...] about Lightlake appoints Kevin Pollack as CFO
News
Hovione and Solvias to collaborate on co-crystals
Inhalation and particle engineering specialist Hovione and Swiss chemical development company Solvias have announced an agreement to collaborate on development and manufacturing of co-crystallized drugs. According to Hovione, "This strengthens Hovione's expertise and experience in overcoming drug delivery challenges and also the supply of GMP materials from phase I to … [Read more...] about Hovione and Solvias to collaborate on co-crystals
FDA issues letter to Alcon over Patanase marketing
The FDA issued a letter to Alcon dated November 13, 2012 regarding a sales aid that the agency says overstates the efficacy of Alcon's Patanase olopatadine hydrochloride nasal spray. In the four-page letter, the agency cites numerous examples of what it says are overstatements of the product's onset of action and the duration of relief and then requests that Alcon … [Read more...] about FDA issues letter to Alcon over Patanase marketing
Next Breath announces successful FDA inspection
Maryland-based CRO Next Breath, which specializes in OINDP analysis, has announced that an October 15, 2012 GMP inspection by the FDA found the company's Baltimore facility to be compliant. The inspection resulted in no Form 483 and no observations. Earlier this year, the World Health Organization (WHO) accredited Next Breath as a testing facility for nasal spray … [Read more...] about Next Breath announces successful FDA inspection
Presspart hires Ameet Sule to head its Inhalation Product Technology Centre
OINDP component manufacturer Presspart has announced the appointment of Ameet Sule as Director of its new Inhalation Product Technology Centre (IPTC) in Blackburn, UK. Sule, who was most recently Director of Pulmonary Research at Lupin, will head the IPTC beginning January 15, 2013. He has almost 20 years of experience with respiratory delivery devices, formulations, … [Read more...] about Presspart hires Ameet Sule to head its Inhalation Product Technology Centre
Unigene says EMA recommendation against calcitonin nasal sprays “catastrophic”
Fortical salmon calcitonin nasal spray manufacturer Unigene says that it is in danger of running out of cash before the end of the first quarter of 2013, due in part to the EMA's July 2012 warning against the use of calcitonin nasal sprays. Unigene President and CEO Ashleigh Palmer said, "The impact of the EMA’s recommendation represents a devastating setback and … [Read more...] about Unigene says EMA recommendation against calcitonin nasal sprays “catastrophic”
Study shows Aradigm’s Lipoquin protects against plague in mice
A study by scientists from the UK Defence Science and Technology Laboratory (Dstl) showed that a single dose of Aradigm's Lipoquin liposomal ciprofloxacin administered through the nose fully protected mice exposed to an aerosolized "lethal dose" of Yersinia pestis. Inhaled aerosolized Lipoquin provided 70% protection, while untreated mice and those given a single dose … [Read more...] about Study shows Aradigm’s Lipoquin protects against plague in mice
Aptar Pharma appoints Jean-Marc Pardonge President of prescription division
Aptar Pharma has announced the appointment of Jean-Marc Pardonge as President of Aptar Pharma’s Prescription Division, succeeding Salim Haffar, and as General Manager of Aptar Stelmi. Aptar's prescription division develops and manufactures a range of nasal and pulmonary delivery devices. Pardonge has worked in the prescription division since 2000, first as R&D … [Read more...] about Aptar Pharma appoints Jean-Marc Pardonge President of prescription division
Marinomed gets Chinese patent for polymer used in anti-viral nasal spray
Vienna, Austria-based Marinomed has announced the granting of Chinese patent No. CN101678040, titled "Antiviral Polymer," for a component of its Mavirex technology platform. According to the company, the patent covers prevention and treatment of the common cold using the polymer. Marinomed's Coldamaris nasal spray for the common cold is sold over the counter in … [Read more...] about Marinomed gets Chinese patent for polymer used in anti-viral nasal spray
Copley launches pump for high flow rate cascade impaction
Copley Scientific has officially launched the SCP5 Super Capacity Pump which is capable of generating flow rates as high as 100 L/min for cascade impaction of dry powder inhalers. The new model, a 1.5 kW oil-lubricated rotary vane pump, allows labs to use a single pump for DPI testing instead of having to use two smaller pumps to generate the required flow. … [Read more...] about Copley launches pump for high flow rate cascade impaction